Our study identified both shared (e.g., T2DM, lipid metabolism, and EGFR signaling) and distinct (e.g., mTOR, PI3K, and ERBB4 signaling for IR) molecular pathways underlying IGF-I/IR axis regulation. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.